2-nitrophenyl-egta has been researched along with 8-bromocyclic gmp in 1 studies
| Studies (2-nitrophenyl-egta) | Trials (2-nitrophenyl-egta) | Recent Studies (post-2010) (2-nitrophenyl-egta) | Studies (8-bromocyclic gmp) | Trials (8-bromocyclic gmp) | Recent Studies (post-2010) (8-bromocyclic gmp) |
|---|---|---|---|---|---|
| 57 | 0 | 8 | 1,516 | 2 | 93 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itofusa, R; Kamiguchi, H; Tojima, T | 1 |
1 other study(ies) available for 2-nitrophenyl-egta and 8-bromocyclic gmp
| Article | Year |
|---|---|
The nitric oxide-cGMP pathway controls the directional polarity of growth cone guidance via modulating cytosolic Ca2+ signals.
Topics: Animals; Calcium Signaling; Cell Polarity; Cells, Cultured; Chick Embryo; Cyclic AMP; Cyclic GMP; Cyclic N-Oxides; Cytosol; Egtazic Acid; Enzyme Inhibitors; Free Radical Scavengers; Ganglia, Spinal; Growth Cones; Imidazoles; Lasers; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Ryanodine Receptor Calcium Release Channel; Time Factors | 2009 |